Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Ondansetron to Prevent ORS Failure in Children With Cholera: A Phase IIa Trial

NCT07795060 is registered in ClinicalTrials.gov with Public Interest Science Center as lead sponsor.

NCT NCT07795060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07795060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Ondansetron to Prevent ORS Failure in Children With Cholera: A Phase IIa Trial
Lead sponsor
Public Interest Science Center
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 1, 2027
Completion date
January 1, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholera (disorder)